StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: United Therapeutics Corporation

Enter Symbol or Keywords

United Therapeutics' OPS Ranking of "5" Reiterated by StockDiagnostics.com

Stock Quote: (NasdaqNM:UTHR)

11/03/2009

58.60

-0.03

-0.05%

133,228

United Therapeutics' OPS Ranking of "5" Reiterated by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 3, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "5" for United Therapeutics Corporation (NASDAQ:UTHR). United Therapeutics has had an OPS Ranki ... read full story

Website Address:	www.unither.com
Industry:	Vaccine, Antibodies, Immunities

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: UTHR

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: UTHR

11/05/2009

United Therapeutics' EBITDA Turns Negative for its Twelve Months

11/04/2009

T12-NEWS reports that the Revenue of United Therapeutics for its 12 month ended September 30, 2009 Increased by 26.83%

11/03/2009

United Therapeutics' OPS Ranking of "5" Reiterated by StockDiagnostics.com

... more UTHR exclusives

Other News Sources: UTHR

02/10/2010

Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction

02/09/2010

United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010

02/03/2010

Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Global Strategic Partnership Agreement for the Development Of Aviptadil Platform

... more UTHR news from other sources

Daily Market Updates

02/10/2010

Futures Flat After December Trade Deficit Widens to $40.2 Billion

Futures fell off their highs in the premarket after the December trade deficit was reported to have widened to $40.2 billion from $36.4 billion in November on a sharp gain in imports. That was much higher than the expected deficit of $36.8 billion. F ... read full story